Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/12/18 → 31/12/20 |
PrevANZ: Phase IIb Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Trial of Vitamin D3 in Patients with a First Demyelinating Event.
- Butzkueven, Helmut (Primary Chief Investigator (PCI))
Project: Research